RT @UCLBrainScience
(1/9) Momentous news today: a clinical trial shows that #Alzheimers drug #lecanemab reduces amyloid in the brain & slows cognitive decline in patients. This breakthrough has been hailed as "the beginning of the end" for Alzheimer’s treatments by Prof John Hardy @UCLIoN @UKDRI 🧵